image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.7709
-0.0862 %
$ 125 M
Market Cap
92.69
P/E
BALANCE SHEET
351 M ASSETS
-25.51%
652 M LIABILITIES
-20.20%
-301 M EQUITY
12.98%
BALANCE SHEET DECOMPOSITION
Balance Sheet Ironwood Pharmaceuticals, Inc.
image
Current Assets 182 M
Cash & Short-Term Investments 88.6 M
Receivables 81.9 M
Other Current Assets 11.9 M
Non-Current Assets 169 M
Long-Term Investments 0
PP&E 15.5 M
Other Non-Current Assets 153 M
25.24 %23.34 %3.40 %4.42 %43.61 %Total Assets$350.9m
Current Liabilities 38.8 M
Accounts Payable 2.13 M
Short-Term Debt 3.19 M
Other Current Liabilities 33.5 M
Non-Current Liabilities 613 M
Long-Term Debt 596 M
Other Non-Current Liabilities 17.1 M
5.14 %91.42 %Total Liabilities$652.2m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007
ASSETS
Cash & Cash Equivalents 88.6 92.2 656.2 620.1 362.6 177.0 173.2 125.7 54.0 261.3 74.3 75.5 136.7 87.3 44.3 123.1 67.7 62.4
Short Term Investments 0 0 0 0 0 0 0 95.7 251.2 178.1 174.0 122.1 31.5 76.7 203.7 0 22.0 29.5
Receivables 81.9 129.1 115.5 114.0 122.4 117.2 81.0 82.2 64.9 54.5 25.8 3.2 1.5 0.7 2.9 5.2 7.1 25.5
Inventory 0 0 1.2 1.2 1 0.6 0 0.7 1.1 0 5.0 22.1 6.7 0 (239.9) 0 2.5 0
Other Current Assets 11.9 12.0 9.0 11.1 10.9 11.9 12.3 7.3 9.0 6.3 10.6 6.2 8.0 2.9 8.2 5.7 11.2 1.7
Total Current Assets 182.4 233.3 780.6 745.2 495.8 306.9 266.4 311.6 380.2 500.2 289.7 229.1 184.4 167.6 259.1 131.4 108.1 119.2
PP&E 15.5 18.2 20.3 22.9 25.5 30.2 17.3 17.3 20.5 21.1 29.8 37.4 37.5 33.6 34.4 22.6 24.6 4.1
Intangible Assets 2.9 3.7 0 0 0 0 0 159.9 166.1 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0.8 0.8 0.8 0.8 0.8 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 15.1 24.5 37.0 64.9 47.4 115.2 140.8 95.2 0 0 0 0 0 0 0 0
Other Long Term Assets 5.9 3.6 15.9 25.5 37.1 64.9 47.6 116.1 142.2 2.6 14.0 12.5 7.9 7.8 7.9 8.5 8.0 12.6
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 350.9 471.1 1 100.5 1 126.9 559.2 402.7 332.1 605.7 709.8 619.1 333.5 279.0 229.9 209.0 301.4 162.5 140.7 135.9
LIABILITIES
Accounts Payable 2.1 7.8 0.5 0.9 0.7 5.5 14.9 16.0 17.7 8.6 9.8 10.2 21.7 6.4 4.3 4.8 3.7 5.6
Short Term Debt 3.2 202.7 6.1 120.0 6.3 2.3 47.6 8.2 12.5 30.2 13.6 2.3 0.5 0.5 0.4 1.6 1.1 1.0
Other Current Liabilities 33.0 64.3 18.3 40.6 25.3 32.3 57.0 41.9 61.0 30.5 30.0 23.5 29.3 21.9 19.7 17.7 30.7 7.5
Total Current Liabilities 38.8 276.1 25.5 161.7 32.7 40.9 119.5 66.0 91.1 76.5 60.5 41.0 54.9 65.1 64.4 56.4 39.2 29.9
Long Term Debt 596.3 512.9 412.9 355.8 450.6 452.2 366.3 396.1 366.7 354.2 163.3 177.8 0.3 0.4 0.4 1.9 1.1 2.0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 81.7 (2.6) 8.8 11.6 (0.4) (14.6) (0.1) (0.2) 0
Other Liabilities 17.1 28.4 9.8 3.5 13.9 2.9 42.6 133.7 185.3 91.5 12.1 10.5 12.6 12.4 14.6 308.8 273.4 223.8
Total Liabilities 652.2 817.4 448.1 521.0 496.6 496.0 528.4 595.8 643.1 524.0 245.0 240.7 85.9 99.1 141.8 460.8 371.1 314.3
EQUITY
Common Stock 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 99 K 8 K 7 K 7 K
Retained Earnings (1 697.7) (1 698.6) (696.4) (937.6) (1 466.1) (1 572.2) (1 591.1) (1 308.8) (1 191.8) (1 110.1) (967.4) (777.8) (505.0) (432.4) (367.5) (314.6) (243.4) (189.5)
Other Accumulative Comprehensive Income/Loss 0.9 (3.0) 0 0 0 0 0 79 K 7 K 86 K 19 K 2 K 5 K 6 K 1 K (298.4) 23 K 3 K
Total Equity (301.3) (346.3) 652.4 605.9 62.6 (93.3) (196.4) 9.8 66.7 95.1 88.6 38.2 144.1 109.9 159.6 (298.3) (230.4) (178.4)
Total Liabilities and Equity 350.9 471.1 1 100.5 1 126.9 559.2 402.7 332.1 605.7 709.8 619.1 333.5 279.0 229.9 209.0 301.4 162.5 140.7 135.9
SHARES OUTSTANDING
Common Shares Outstanding 159.1 155.4 154.4 162.2 159.4 156.0 152.6 148.4 144.9 142.2 136.8 115.9 106.4 99.9 89.7 7.1 6.9 7.1 94.9